相似文献
1
A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.
J Assist Reprod Genet. 2000 Feb;17(2):107-12. doi: 10.1023/a:1009418017662.
2
The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Hum Reprod. 1996 Jun;11(6):1209-13. doi: 10.1093/oxfordjournals.humrep.a019357.
3
Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Gynecol Endocrinol. 1998 Feb;12(1):9-15. doi: 10.3109/09513599809024964.
4
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Hum Reprod. 1996 Nov;11(11):2400-4. doi: 10.1093/oxfordjournals.humrep.a019123.
5
The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.
J Assist Reprod Genet. 1996 May;13(5):395-400. doi: 10.1007/BF02066171.
6
A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:70-3. doi: 10.1016/j.ejogrb.2013.10.027. Epub 2013 Nov 5.
7
Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Jun;55(6):452-6.
8
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359.
9
Placental protein 14 concentrations in circulation related to hormonal parameters and reproductive outcome in women undergoing IVF/ICSI.
Reprod Biomed Online. 2004 Jan;8(1):91-8. doi: 10.1016/s1472-6483(10)60502-0.
10
The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer.
J Assist Reprod Genet. 1999 Jul;16(6):287-93. doi: 10.1023/a:1020496330424.
引用本文的文献
1
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
本文引用的文献
1
Effect of parental age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection.
Hum Reprod. 1998 Feb;13(2):334-8. doi: 10.1093/humrep/13.2.334.
2
Crossover designs versus parallel studies in infertility research.
Fertil Steril. 1998 Feb;69(2):357-8. doi: 10.1016/s0015-0282(97)00491-3.
3
Predictive factors for multiple pregnancy in in vitro fertilization.
J Reprod Med. 1997 Dec;42(12):761-6.
4
Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
Hum Reprod. 1997 Oct;12(10):2133-9. doi: 10.1093/humrep/12.10.2133.
5
Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Hum Reprod. 1996 Nov;11(11):2400-4. doi: 10.1093/oxfordjournals.humrep.a019123.
6
A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme.
Hum Reprod. 1996 Sep;11(9):1864-70. doi: 10.1093/oxfordjournals.humrep.a019508.
7
Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity.
Hum Reprod. 1996 Sep;11(9):1854-8. doi: 10.1093/oxfordjournals.humrep.a019506.
8
One year's experience with elective transfer of two good quality embryos in the human in-vitro fertilization and intracytoplasmic sperm injection programmes.
Hum Reprod. 1995 Dec;10(12):3305-12. doi: 10.1093/oxfordjournals.humrep.a135908.
9
The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Hum Reprod. 1996 Jun;11(6):1209-13. doi: 10.1093/oxfordjournals.humrep.a019357.
10
Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure.
Fertil Steril. 1996 May;65(5):939-45. doi: 10.1016/s0015-0282(16)58265-x.
Zotero 插件